RPL39

Large ribosomal subunit protein eL39 (60S rib · P62891 · RPL39 on Sugi Atlas →

0 patent compounds predicted against RPL39, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL39 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES PHASE3UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis PHASE1/PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors PHASE1COMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
RibOSE - Glucose and Resistance Exercise Training nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus nanCOMPLETED
Perfusion-Induced Hyperthermia for Metastatic Carcinoma nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia nanCOMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN

Related proteins — ESM-2 sequence neighbours (a RPL39 binder may also engage these)

ProteinNameSimilarity
Q3T051 1.000 Q3T051 →
G1SYU7 1.000 G1SYU7 →
P62892 1.000 P62892 →
P62893 1.000 P62893 →
Q9CQD0 1.000 Q9CQD0 →
Q98TF5 1.000 Q98TF5 →
Q90YS9 1.000 Q90YS9 →
Q59GN2 1.000 Q59GN2 →
Q96W55 0.999 Q96W55 →
P52814 0.998 P52814 →
P51425 0.998 P51425 →
Q6KAJ8 0.997 Q6KAJ8 →
P04650 0.997 P04650 →
Q5SMI4 0.997 Q5SMI4 →
A0A1D8PDT4 0.997 A0A1D8PDT4 →
Q6F482 0.995 Q6F482 →
P51426 0.995 P51426 →
Q8L8W6 0.995 Q8L8W6 →
Q962S4 0.995 Q962S4 →
Q6BHV8 0.995 Q6BHV8 →
P05767 0.994 P05767 →
Q758D8 0.994 Q758D8 →
Q5JGT6 0.993 Q5JGT6 →
P51424 0.992 P51424 →
Q6CW22 0.992 Q6CW22 →
Q6M0V9 0.992 Q6M0V9 →
O27650 0.992 O27650 →
O16130 0.991 O16130 →
Q96EH5 0.991 Q96EH5 →
P54056 0.991 P54056 →